Cyclacel Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $10 | $4 | $29 | $31 |
Gross Profit | 10 | 2 | 27 | 23 |
EBITDA | -2,176 | -3,642 | -4,353 | -5,752 |
EBIT | -2,177 | -3,644 | -4,355 | -5,760 |
Net Income | -1 | -3,257 | -2,946 | -5,271 |
Net Change In Cash | 10 | 4 | 29 | 31 |
Free Cash Flow | -3,067 | -3,084 | -483 | -3,910 |
Cash | 2,982 | 6,000 | 2,798 | 3,378 |
Basic Shares | 2,152 | 1,805 | 1,297 | 854 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43 | $420 | $373 | $0 |
Gross Profit | 43 | 420 | -32 | -43 |
EBITDA | -25,422 | -27,889 | -22,691 | |
EBIT | -25,453 | -27,656 | -22,734 | |
Net Income | -11,212 | -22,555 | -21,198 | -18,887 |
Net Change In Cash | 43 | 420 | 373 | 0 |
Free Cash Flow | -7,990 | -16,117 | -20,834 | -18,567 |
Cash | 3,137 | 3,378 | 18,345 | 36,559 |
Basic Shares | 850 | 657 | 595 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.18 |
2024-06-30 | -$0.72 |
2024-03-31 | -$2.27 |
2023-12-31 | -$6.23 |
